In this study, we added further insights into THC anti-tumor action, showing its ability to modify the number of Ki67+ cells of human patient-derived GBM cells, particularly through the activation of the orphan receptor GPR55 without affecting CB1 and CB2 receptors as usual targets. The gene discussed is GPR55; the disease is neoplasm.